Moira C Graves

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Top Venues

Cancer research communications

British journal of clinical pharmacology

Cellular oncology (Dordrecht)

Pharmacology research & perspectives

Australia Rickettsial Reference Laboratory

University of Sydney Faculty of Science (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Australia Rickettsial Reference Laboratory

Australia

Director

The University of Newcastle Jan 01 2018

Australia

Post-doctoral Researcher :: School of Medicine and Public Health

University of Newcastle - Dec 31 2017

Australia

Research Assistant :: School of Medicine and Public Health

ARRL Ethics and Animal Care Committee

Australia

Chairman

Education History

University of Sydney Faculty of Science

Australia

MSC :: Faculty of science

Queensland University of Technology Feb 23 1981

Australia

BSC

Publications

Andre van der Westhuizen, Megan Lyle, Moira C Graves, Xiaoqiang Zhu, Jason Wing Hon Wong, Kerrie Cornall, Shu Ren, Leanna Pugliese, Richard Levy, Adeeb Majid, Ricardo E Vilain, Nikola A Bowden
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge. Cancer research communications 2 (8) (2022)
Vishal Navani, Moira C Graves, Giovana Celli Marchett, Hiren Mandaliya, Nikola A Bowden, Andre van der Westhuizen
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers. Pharmacology research & perspectives 9 (4) (2022)
Mathew Lozinski, Nikola A Bowden, Moira C Graves, Michael Fay, Paul A Tooney
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets. Cellular oncology (Dordrecht) 44 (5) (2021)
Vishal Navani, Moira C Graves, Nikola A Bowden, Andre Van Der Westhuizen
Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response. British journal of clinical pharmacology 86 (9) (2020)